FDA Clearance Tracker · P180046-S062
Axonics Sacral Neuromodulation System (Urinary)
Last checked: Nov 20, 2026Latest source record: Dec 19, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Dec 19, 2022
Approved
Time to decision
81 days
Received Sep 29, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P180046-S062
- Device name
- Axonics Sacral Neuromodulation System (Urinary)
- Applicant
- Boston Scientific Corporation
- Applicant location
- Marlborough, MA
- Received
- Sep 29, 2022
- Decided
- Dec 19, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P180046
Device type
- Device class
- Class III
- Regulation
- 21 CFR 876.5270
FDA's approval statement
As written in FDA's record.
Approval for updated labeling information
Source documents
Other decisions for Boston Scientific Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SpaceOAR Flex System510(k)
K262151 · Decided Sep 11, 2026 · 78 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.